Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Size

Daily deal net: October 14, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Mogrify develops $16m series A
Ahren Innovation Capital has led a $16m initial series A tranche for Mogrify, co-founded by researchers from Bristol, Monash and Duke universities.
Daily deal net: October 11, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
IM Therapeutics seizes $10m series A
University of Colorado-founded IM Therapeutics has received $10m from investors including the university's Healthcare Innovation Fund to advance a treatment for type 1 diabetes.
Lilium looks to Tencent for $500m round
Existing investor Tencent is in talks as part of a round TUM's flying car developer reportedly aims to close at between $400m and $500m.
Daily deal net: October 10, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Fazua stays unfazed to collect $16.5m
UVC Partners returned to back Fazua together with the electric bike drive system maker's other existing investors and an EIB-run venture debt provider.
Biontech binds itself to public markets
Johannes Gutenberg University of Mainz's cancer therapy developer raised $150m despite reducing the number of shares in the IPO and floating beneath its range.

News Continued

Aprea closes $97.8m IPO
The underwriters for Karolinska Institute spinout Aprea Therapeutics have taken up the over-allotment option in full to boost proceeds to nearly $97.8m.
Daily deal net: October 8, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
MiroBio signals for $33.1m
University of Oxford-founded autoimmune disease therapy developer MiroBio has launched with support from OSI and GlaxoSmithKline’s SR One.
Daily deal net: October 7, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Apple screens iKinema for acquisition
Founded from University of Surrey's Space Centre, iKinema was bought by Apple in a move seemingly aligned with the corporate's foray into virtual and augmented reality.
Daily deal net: October 4, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
test reg

Login